SlideShare a Scribd company logo
Origins of the Heroin Crisis
Presenters:
• Phillip Walls, RPh, Chief Clinical Officer, myMatrixx
• Andrew Kolodny, MD, Chief Medical Officer, Phoenix House
Foundation, Inc., and Executive Director, Physicians for
Responsible Opioid Prescribing
Moderator: Jackie L. Steele, Jr., JD, Commonwealth
Attorney, Kentucky 27th Judicial Circuit, and Vice
Chairman, Operation UNITE Board of Directors
Heroin Track
Disclosures
• Andrew Kolodny, MD, and Jackie L. Steele, Jr.,
JD, have disclosed no relevant, real or
apparent personal or professional financial
relationships with proprietary entities that
produce health care goods and services.
• Phil Walls, RPh - Employment and ownership
interest: Matrix HCS, Inc.
Disclosures
• All planners/managers hereby state that they or their
spouse/life partner do not have any financial
relationships or relationships to products or devices
with any commercial interest related to the content of
this activity of any amount during the past 12 months.
• The following planners/managers have the following to
disclose:
– John J. Dreyzehner, MD, MPH, FACOEM – Ownership
interest: Starfish Health (spouse)
– Robert DuPont – Employment: Bensinger, DuPont &
Associates-Prescription Drug Research Center
Learning Objectives
• Describe the history of heroin use in America, with
emphasis on its relationship to the Rx drug abuse
epidemic.
• Identify key roles for pharmacists and other health
professionals in identifying patients at-risk of heroin
abuse.
• Explain the relationship between the rising rates of
opioid addiction, heroin use and overdose deaths.
• Specify health interventions and policy responses to
the heroin crisis.
• Provide accurate and appropriate counsel as part of
the treatment team.
Heroin Track:
Origins of the Heroin Crisis
Why Focus on Heroin?
• $177 billion – annual cost of prescription drug abuse to
the US healthcare system
• The Drug Enforcement Administration (DEA) estimates
that diversion is a $25 billion-a-year industry
• $8.5 billion – annual cost of hospital admissions for people
who do not take their medications as prescribed
How did this happen?
Prescription Drug Abuse,
Misuse and Diversion
Timeline to Discovery of Heroin
• 1806 – morphine isolated from opium poppy – named after Morpheus,
the Greek god of dreams
– Heinrick Emanuel Merck – converted pharmacy into a full-time
producer of morphine – Engel-Apotheke or The Angel Pharmacy
– Today known as Merck and Company
• 1853 – invention of the hypodermic syringe and first
injection of morphine
– Co-invented by Alexander Wood and Charles Pravaz
– Woods’ wife was the first fatality of an injected overdose of
morphine
Alexander Wood
(1817 – 1884)
Timeline to Discovery of Heroin
• Dr. Woods’ discovery preceded the American Civil War by
almost a decade
– Approximately 400,000 soldiers became addicted to morphine
– Characterized as “old soldiers’ disease”
• One of these veteran’s was Colonel John Pemberton
– A pharmacist by training
– Mixed cocaine and the kola nut in an elixir to treat morphine
withdrawal
– Branded as Coca Cola in 1886
– Original formula with cocaine available until 1905
• 1874 - Diacetylmorphine is first synthesized
Timeline to Discovery of Heroin
Between 1878 and 1885 however opium addiction became much
more widespread among middle- to upper-class white women
Timeline to Discovery of Heroin
• Diacetylmorphine is “re-discovered” by
chemists working for Friedrich Bayer in the
mid-1880’s through a process known as
acetylation
– Morphine → diacetylmorphine
– Acetylsalicylic acid → aspirin
• Bayer named this drug heroin after the
German word heros meaning hero.
Morphine
Heroin
The two drugs differ
by the addition of
two acetyl groups
Metabolism of Opioids
*Not comprehensive pathways, but may explain the presence of apparently
unprescribed drugs
†6-MAM=6-monoacetylmorphine, an intermediate metabolite
Gourlay DL, et al. Urine Drug Testing in Clinical Practice: Dispelling the Myths & Designing Strategies [monograph]. 2004
hydrocodone
heroin6-MAM†
morphinecodeine
hydromorphone
oxycodone oxymorphone
Timeline to Discovery of Heroin
• Aspirin was first synthesized a year
later – ironically aspiring required a
prescription whereas heroin did
not
• Bayer and Merck had launched the
start of the modern day
pharmaceutical industry with the
development of three of the
world’s most popular analgesics:
morphine, heroin and aspirin
Trial Treatment – Free of Charge!
The Solution for Coughs
Early Attempts at Regulation
• 1906 – Pure Food and Drug Act – Coca Cola was
one of few products that survived this legislation
• 1914 – Harrison Narcotic Act
• 1919 – ruling by the Supreme Court that it was
unconstitutional to stop physicians from
prescribing narcotics for addicts, but then the
court later reversed that decision
• The case of Alexander Ameris – characterized as a
“dope fiend”
Prevailing attitude early to mid-
century
1900
• “…save our people from the clutches of this hydra-
headed monster which stalks the civilized world,
wrecking lives and happy homes, filling our jails and
lunatic asylums…”
Witherspoon JA. A protest against some of the evils in the profession of medicine. JAMA. 1900;34 :1589–
1592
1941
• “The use of narcotics in the terminal cancer patient is
to be condemned … due to undesirable side effects …
dominant in the list of these … is addiction”
Lee LE Jr. Medication in the control of pain in terminal cancer. JAMA 1941;116:216-219
The Vietnam War Era
• Represented a turbulent time in American history
• Janis Joplin dies of a heroin overdose on October 4, 1970
• The following May, Congressmen Steele and Murphy
conducted an official visit to Vietnam
• Their message upon returning: 15% of US servicemen in
Vietnam were addicted to heroin
• The timing coincided with the implementation of the
Comprehensive Drug Abuse Prevention and Control Act of
1970
• On June 17th of 1971, President Richard Nixon characterized
drug abuse as “a national emergency” - He asked Congress
to amend the Narcotic Addict Rehabilitation Act of 1966 to
increase access to methadone maintenance programs
America’s War on Drugs
• President Nixon’s legacy includes creation of the Drug
Enforcement Administration in 1973
• 1975: the Ford administration names marijuana a low-
priority drug
• 1976: Carter campaigns for de-criminalization of marijuana
• 1978: the Comprehensive Drug Abuse Prevention and
Control Act is amended to allow law enforcement to seize
“all things of value” involved in and exchange for controlled
substances
• 1981 – 1982: rise of the Medellin Cartel in Columbia and
creation of a bilateral extradition treaty between the
governments of Colombia and the United States
America’s War on Drugs
• 1984: Nancy Reagan launches her “Just Say No” campaign, which
becomes a focal point of President Reagan’s anti-drug campaign
• 1989: President Bush creates the Office of National Drug Control Policy
(ONDCP) and campaigns to “make drug abuse socially unacceptable”.
Spending for treatment and law enforcement increase under the
ONDCP, but the budget for treatment is less than one-third that of law
enforcement.
• 1993: President Clinton signs the North American Free Trade
Agreement (NAFTA). This agreement results in a significant increase in
legitimate trade shipments across the Mexican-US border, but has the
unintended consequence of making it difficult for US Customs agents
to find contraband narcotics in these shipments.
• 2000: President Clinton commits $1.3 billion in aid to Colombia to fight
drug trafficking.
America’s War on Drugs
It is important to note in
the War on Drugs that the
DEA announced just this
past May the most
successful enforcement
action in its history:
known as Operation
Pilluted, this operation
resulted in 280 arrests
including 22 doctors and
pharmacists; resulted in
the seizure of $11,651,565
US currency and
$6,745,800 in real
property.
The Prescription Opioid & Heroin Crisis:
Responding to an Epidemic of Addiction
Andrew Kolodny, M.D.
Chief Medical Officer, Phoenix House Foundation Inc.
Executive Director, Physicians for Responsible Opioid Prescribing
Senior Scientist, Heller School for Social Policy and Management, Brandeis University
Opium
Primary non-heroin opiates/synthetics admission rates, by State
(per 100,000 population aged 12 and over)
Primary non-heroin opiates/synthetics admission rates, by State
(per 100,000 population aged 12 and over)
Primary non-heroin opiates/synthetics admission rates, by State
(per 100,000 population aged 12 and over)
Primary non-heroin opiates/synthetics admission rates, by State
(per 100,000 population aged 12 and over)
Primary non-heroin opiates/synthetics admission rates, by State
(per 100,000 population aged 12 and over)
Primary non-heroin opiates/synthetics admission rates, by State
(per 100,000 population aged 12 and over)
Non-heroin opioid treatment admissions: 2013
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services
Administration, Treatment Episode Data Set (TEDS). Data received through 01.23.15.
Unintentional overdose deaths involving opioid analgesics
parallel per capita sales of opioid analgesics in morphine
equivalents by year, U.S., 1997-2007
0
100
200
300
400
500
600
700
800
0
2000
4000
6000
8000
10000
12000
14000
'97 '98 '99 '00 '01 '02 '03 '04 '05 '06 '07
Source: National Vital Statistics System, multiple cause of death dataset, and DEA ARCOS
* 2007 opioid sales figure is preliminary.
Number of
Deaths
Opioid sales
(mg/person)
*
0
1
2
3
4
5
6
7
8
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Rate
Year
Opioid Sales KG/10,000 Opioid Deaths/100,000 Opioid Treatment Admissions/10,000
Rates of Opioid Sales, OD Deaths, and Treatment, 1999–2010
CDC. MMWR 2011
Source: United States General Accounting Office: Dec. 2003, “OxyContin Abuse and Diversion and
Efforts to Address the Problem.”
Dollars Spent Marketing OxyContin (1996-2001)
Industry-funded “educational” messages
• Physicians are needlessly allowing patients to suffer
because of “opiophobia.”
• Opioid addiction is rare in pain patients.
• Opioids can be easily discontinued.
• Opioids are safe and effective for chronic pain.
Industry-funded organizations campaigned for
greater use of opioids
• Pain Patient Groups
• Professional Societies
• The Joint Commission
• The Federation of State Medical Boards
Porter J, Jick H. Addiction rare in patients treated with
narcotics. N Engl J Med. 1980 Jan 10;302(2):123
Cited 824 times (Google Scholar)
“The risk of addiction is much less than 1%”
N Engl J Med. 1980 Jan 10;302(2):123.
0
2,000
4,000
6,000
8,000
10,000
12,000
14,000
16,000
18,000
20,000
22,000
24,000
26,000
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Painkillers Heroin Total Opioid
Year
Opioid Related Overdose Deaths: 1999-2013
Heroin treatment admissions : 2003-2013
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services
Administration, Treatment Episode Data Set (TEDS). Data received through 01.23.15.
Death rates from overdoses of heroin or prescription opioid
pain relievers (OPRs), by age group
SOURCE: CDC. Increases in Heroin Overdose Deaths — 28 States, 2010 to 2012
MMWR. 2014, 63:849-854
Heroin admissions, by gender, age, and race/ethnicity:
2013
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health
Services Administration, Treatment Episode Data Set (TEDS). Data received through 01.23.15.
Deaths involving heroin, by age and race/ethnicity
2000 and 2013
Controlling the epidemic:
A Three-pronged Approach
• Prevent new cases of opioid addiction.
• Treatment for people who are already addicted
• Reduce supply from pill mills and the black-
market.
How the opioid lobby frames the problem:
Source: Slide presented by Lynn R. Webster MD at FDA meeting on
hydrocodone upscheduling, January 25th, 2013.
Pain Patients “Drug Abusers”
35% met DSM V criteria for an opioid
use disorder1
1. Boscarino JA, Rukstalis MR, Hoffman SN, et al. Prevalence of prescription opioid-use disorder among chronic pain patients:
comparison of the DSM-5 vs. DSM-4 diagnostic criteria. J Addict Dis. 2011;30:185-194.
This is a false dichotomy
Opioid harms are not limited to so-called “drug abusers”
92% of opioid OD decedents
were prescribed opioids for
chronic pain.2
2. Johnson EM, Lanier WA, Merrill RM, et al. Unintentional Prescription Opioid-Related Overdose Deaths: Description of
Decedents by Next of Kin or Best Contact, Utah, 2008-2009. J Gen Intern Med. 2012 Oct 16.
Heroin treatment admissions with planned
medication-assisted opioid therapy 2003-2013
SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services
Administration, Treatment Episode Data Set (TEDS). Data received through 01.23.15.
Summary
• The U.S. is in the midst of a severe epidemic of
opioid addiction
• To bring the epidemic to an end:
– We must prevent new cases of opioid addiction
– We must ensure access to treatment for people
already addicted
Origins of the Heroin Crisis
Presenters:
• Andrew Kolodny, MD, Chief Medical Officer, Phoenix House
Foundation, Inc., and Executive Director, Physicians for
Responsible Opioid Prescribing
• Phillip Walls, RPh, Chief Clinical Officer, myMatrixx
Moderator: Jackie L. Steele, Jr., JD, Commonwealth
Attorney, Kentucky 27th Judicial Circuit, and Vice Chairman,
Operation UNITE Board of Directors
Heroin Track

More Related Content

What's hot

Rx16 vs claad_tues_800_group
Rx16 vs claad_tues_800_groupRx16 vs claad_tues_800_group
Rx16 vs claad_tues_800_group
OPUNITE
 
Rx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3greenRx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3green
OPUNITE
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
OPUNITE
 
Rx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendezRx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendez
OPUNITE
 
Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
OPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
OPUNITE
 
Rx16 vs nadcp_tues_800_1_walton
Rx16 vs nadcp_tues_800_1_waltonRx16 vs nadcp_tues_800_1_walton
Rx16 vs nadcp_tues_800_1_walton
OPUNITE
 
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldRx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
OPUNITE
 
Rx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harrisRx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harris
OPUNITE
 
Rx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gormanRx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gorman
OPUNITE
 
Rx16 federal tues_200_1_gladden_2halpin_3green
Rx16 federal tues_200_1_gladden_2halpin_3greenRx16 federal tues_200_1_gladden_2halpin_3green
Rx16 federal tues_200_1_gladden_2halpin_3green
OPUNITE
 
Rx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2greenRx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2green
OPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
OPUNITE
 
Rx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_groupRx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_group
OPUNITE
 
Rx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manloveRx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manlove
OPUNITE
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
OPUNITE
 
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdevaRx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
OPUNITE
 
View only rx16 prev tues_1230_1_duwve_2adams_3proescholdbell-sachdeva
View only rx16 prev tues_1230_1_duwve_2adams_3proescholdbell-sachdevaView only rx16 prev tues_1230_1_duwve_2adams_3proescholdbell-sachdeva
View only rx16 prev tues_1230_1_duwve_2adams_3proescholdbell-sachdeva
OPUNITE
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
OPUNITE
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
OPUNITE
 

What's hot (20)

Rx16 vs claad_tues_800_group
Rx16 vs claad_tues_800_groupRx16 vs claad_tues_800_group
Rx16 vs claad_tues_800_group
 
Rx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3greenRx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3green
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Rx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendezRx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendez
 
Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Rx16 vs nadcp_tues_800_1_walton
Rx16 vs nadcp_tues_800_1_waltonRx16 vs nadcp_tues_800_1_walton
Rx16 vs nadcp_tues_800_1_walton
 
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldRx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
 
Rx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harrisRx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harris
 
Rx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gormanRx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gorman
 
Rx16 federal tues_200_1_gladden_2halpin_3green
Rx16 federal tues_200_1_gladden_2halpin_3greenRx16 federal tues_200_1_gladden_2halpin_3green
Rx16 federal tues_200_1_gladden_2halpin_3green
 
Rx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2greenRx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2green
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Rx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_groupRx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_group
 
Rx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manloveRx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manlove
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdevaRx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
 
View only rx16 prev tues_1230_1_duwve_2adams_3proescholdbell-sachdeva
View only rx16 prev tues_1230_1_duwve_2adams_3proescholdbell-sachdevaView only rx16 prev tues_1230_1_duwve_2adams_3proescholdbell-sachdeva
View only rx16 prev tues_1230_1_duwve_2adams_3proescholdbell-sachdeva
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 

Viewers also liked

Stop Selling Heroin
Stop Selling HeroinStop Selling Heroin
Stop Selling Heroin
Zebedee Jones
 
Heroin treatment comparison
Heroin treatment comparisonHeroin treatment comparison
Heroin treatment comparison
kokamotoTNJ
 
National Academies of Science and Medicine: Intertwined Epidemics: Opioid and...
National Academies of Science and Medicine: Intertwined Epidemics: Opioid and...National Academies of Science and Medicine: Intertwined Epidemics: Opioid and...
National Academies of Science and Medicine: Intertwined Epidemics: Opioid and...
Dan Ciccarone
 
Prescription Drug Abuse, Daniel Blaney-Koen - SLC 2015
Prescription Drug Abuse, Daniel Blaney-Koen - SLC 2015Prescription Drug Abuse, Daniel Blaney-Koen - SLC 2015
Prescription Drug Abuse, Daniel Blaney-Koen - SLC 2015
American Academy of Family Physicians
 
Heroin
HeroinHeroin
Heroin
Chris Burley
 
FMCC 2016 Curbing Rx Drug Abuse Plenary by Daniel Blaney-Koen
FMCC 2016 Curbing Rx Drug Abuse Plenary by Daniel Blaney-KoenFMCC 2016 Curbing Rx Drug Abuse Plenary by Daniel Blaney-Koen
FMCC 2016 Curbing Rx Drug Abuse Plenary by Daniel Blaney-Koen
American Academy of Family Physicians
 
FMCC 2016 Curbing Rx Drug Abuse Plenary by Christopher Jones
FMCC 2016 Curbing Rx Drug Abuse Plenary by Christopher JonesFMCC 2016 Curbing Rx Drug Abuse Plenary by Christopher Jones
FMCC 2016 Curbing Rx Drug Abuse Plenary by Christopher Jones
American Academy of Family Physicians
 
Opioids part1-2010
Opioids part1-2010Opioids part1-2010
Opioids part1-2010
preksha19dwivedi
 
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
University of Michigan Injury Center
 
Wed gs frieden
Wed gs friedenWed gs frieden
Wed gs frieden
OPUNITE
 
Modern Medical's Opioid Defense Manager™
Modern Medical's Opioid Defense Manager™Modern Medical's Opioid Defense Manager™
Modern Medical's Opioid Defense Manager™
Modern Medical
 
Steph Bonacorsi - Oxycontin Epidemc
Steph Bonacorsi - Oxycontin EpidemcSteph Bonacorsi - Oxycontin Epidemc
Steph Bonacorsi - Oxycontin Epidemc
Stephanie Bonaccorsi
 
The Prescription Drug Epidemic:
The Prescription Drug Epidemic: The Prescription Drug Epidemic:
The Prescription Drug Epidemic:
Rogers Memorial Hospital
 
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
University of Michigan Injury Center
 
Tue gs mc cance-katz
Tue gs mc cance-katzTue gs mc cance-katz
Tue gs mc cance-katz
OPUNITE
 
Cl 4 salsitz
Cl 4 salsitzCl 4 salsitz
Cl 4 salsitz
OPUNITE
 
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_externalWed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
OPUNITE
 
Rx16 pharma tues_200_1_kelly_2ream_3shanehsaz
Rx16 pharma tues_200_1_kelly_2ream_3shanehsazRx16 pharma tues_200_1_kelly_2ream_3shanehsaz
Rx16 pharma tues_200_1_kelly_2ream_3shanehsaz
OPUNITE
 
Rx15 workshop mon_200_aleshire_dowell_no_notes
Rx15 workshop mon_200_aleshire_dowell_no_notesRx15 workshop mon_200_aleshire_dowell_no_notes
Rx15 workshop mon_200_aleshire_dowell_no_notes
OPUNITE
 
National Drug Early Warning (NDEWS) webinar: A more dangerous heroin: Emergin...
National Drug Early Warning (NDEWS) webinar: A more dangerous heroin: Emergin...National Drug Early Warning (NDEWS) webinar: A more dangerous heroin: Emergin...
National Drug Early Warning (NDEWS) webinar: A more dangerous heroin: Emergin...
Dan Ciccarone
 

Viewers also liked (20)

Stop Selling Heroin
Stop Selling HeroinStop Selling Heroin
Stop Selling Heroin
 
Heroin treatment comparison
Heroin treatment comparisonHeroin treatment comparison
Heroin treatment comparison
 
National Academies of Science and Medicine: Intertwined Epidemics: Opioid and...
National Academies of Science and Medicine: Intertwined Epidemics: Opioid and...National Academies of Science and Medicine: Intertwined Epidemics: Opioid and...
National Academies of Science and Medicine: Intertwined Epidemics: Opioid and...
 
Prescription Drug Abuse, Daniel Blaney-Koen - SLC 2015
Prescription Drug Abuse, Daniel Blaney-Koen - SLC 2015Prescription Drug Abuse, Daniel Blaney-Koen - SLC 2015
Prescription Drug Abuse, Daniel Blaney-Koen - SLC 2015
 
Heroin
HeroinHeroin
Heroin
 
FMCC 2016 Curbing Rx Drug Abuse Plenary by Daniel Blaney-Koen
FMCC 2016 Curbing Rx Drug Abuse Plenary by Daniel Blaney-KoenFMCC 2016 Curbing Rx Drug Abuse Plenary by Daniel Blaney-Koen
FMCC 2016 Curbing Rx Drug Abuse Plenary by Daniel Blaney-Koen
 
FMCC 2016 Curbing Rx Drug Abuse Plenary by Christopher Jones
FMCC 2016 Curbing Rx Drug Abuse Plenary by Christopher JonesFMCC 2016 Curbing Rx Drug Abuse Plenary by Christopher Jones
FMCC 2016 Curbing Rx Drug Abuse Plenary by Christopher Jones
 
Opioids part1-2010
Opioids part1-2010Opioids part1-2010
Opioids part1-2010
 
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
 
Wed gs frieden
Wed gs friedenWed gs frieden
Wed gs frieden
 
Modern Medical's Opioid Defense Manager™
Modern Medical's Opioid Defense Manager™Modern Medical's Opioid Defense Manager™
Modern Medical's Opioid Defense Manager™
 
Steph Bonacorsi - Oxycontin Epidemc
Steph Bonacorsi - Oxycontin EpidemcSteph Bonacorsi - Oxycontin Epidemc
Steph Bonacorsi - Oxycontin Epidemc
 
The Prescription Drug Epidemic:
The Prescription Drug Epidemic: The Prescription Drug Epidemic:
The Prescription Drug Epidemic:
 
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
 
Tue gs mc cance-katz
Tue gs mc cance-katzTue gs mc cance-katz
Tue gs mc cance-katz
 
Cl 4 salsitz
Cl 4 salsitzCl 4 salsitz
Cl 4 salsitz
 
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_externalWed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
 
Rx16 pharma tues_200_1_kelly_2ream_3shanehsaz
Rx16 pharma tues_200_1_kelly_2ream_3shanehsazRx16 pharma tues_200_1_kelly_2ream_3shanehsaz
Rx16 pharma tues_200_1_kelly_2ream_3shanehsaz
 
Rx15 workshop mon_200_aleshire_dowell_no_notes
Rx15 workshop mon_200_aleshire_dowell_no_notesRx15 workshop mon_200_aleshire_dowell_no_notes
Rx15 workshop mon_200_aleshire_dowell_no_notes
 
National Drug Early Warning (NDEWS) webinar: A more dangerous heroin: Emergin...
National Drug Early Warning (NDEWS) webinar: A more dangerous heroin: Emergin...National Drug Early Warning (NDEWS) webinar: A more dangerous heroin: Emergin...
National Drug Early Warning (NDEWS) webinar: A more dangerous heroin: Emergin...
 

Similar to Rx16 heroin tues_1115_1_walls_2kolodny

Treating Substance Use Disorders in a Primary Care Setting
Treating Substance Use Disorders in a Primary Care SettingTreating Substance Use Disorders in a Primary Care Setting
Treating Substance Use Disorders in a Primary Care Setting
Mark Scott
 
Treating Substance Use Disorders in a Primary Care Setting
Treating Substance Use Disorders in a Primary Care SettingTreating Substance Use Disorders in a Primary Care Setting
Treating Substance Use Disorders in a Primary Care Setting
Kolmac Outpatient Recovery Centers
 
Pharmaceutics I
Pharmaceutics I Pharmaceutics I
Chapter 1
Chapter 1Chapter 1
Chapter 1
alliedpharmacy
 
Class 7 substance abuse
Class 7 substance abuseClass 7 substance abuse
Class 7 substance abuse
professorgoff
 
Dadspresentationfinal
DadspresentationfinalDadspresentationfinal
Dadspresentationfinal
Heather Voight
 
History of _clinical_research (2)
History of _clinical_research (2)History of _clinical_research (2)
History of _clinical_research (2)
rahilkhan82
 
Regulations for drug approval in USA, E.U & India
Regulations for drug approval in USA, E.U & IndiaRegulations for drug approval in USA, E.U & India
Regulations for drug approval in USA, E.U & India
Dr. Pankaj Bablani
 
Drugs use and addiction
Drugs use and addictionDrugs use and addiction
Drugs use and addiction
Abad Agha
 
Addiction Counselor Certification Training Series: Systems influences on mood...
Addiction Counselor Certification Training Series: Systems influences on mood...Addiction Counselor Certification Training Series: Systems influences on mood...
Addiction Counselor Certification Training Series: Systems influences on mood...
Dr. DawnElise Snipes ★AllCEUs★ Unlimited Counselor Training
 
Student Loan ExerciseThis assignment is an exercise in getting.docx
Student Loan ExerciseThis assignment is an exercise in getting.docxStudent Loan ExerciseThis assignment is an exercise in getting.docx
Student Loan ExerciseThis assignment is an exercise in getting.docx
florriezhamphrey3065
 
Chapter 1 pharmacy and health care
Chapter 1 pharmacy and health careChapter 1 pharmacy and health care
Chapter 1 pharmacy and health care
Ann Bentley
 
Michael-Ward
Michael-WardMichael-Ward
Michael-Ward
OPUNITE
 
J. Listerman_Master's Thesis
J. Listerman_Master's ThesisJ. Listerman_Master's Thesis
J. Listerman_Master's Thesis
Jeffrey Listerman
 
Goldberg Chapter 4
Goldberg Chapter 4Goldberg Chapter 4
Goldberg Chapter 4
Michelle Cottrell
 
Goldberg Chapter 4 Drugs & the Law
Goldberg Chapter 4 Drugs & the LawGoldberg Chapter 4 Drugs & the Law
Goldberg Chapter 4 Drugs & the Law
Michelle Cottrell
 
History that lead to Pharmacovigilance.pptx
History that lead to Pharmacovigilance.pptxHistory that lead to Pharmacovigilance.pptx
History that lead to Pharmacovigilance.pptx
SirajSundaran
 
Lecture 4 history and ethical codes
Lecture 4  history and ethical codesLecture 4  history and ethical codes
Lecture 4 history and ethical codes
Ishah Khaliq
 
Botanicals Scientific Validation of Herbal Medicine
Botanicals  Scientific Validation of Herbal Medicine Botanicals  Scientific Validation of Herbal Medicine
Botanicals Scientific Validation of Herbal Medicine
Ellen Kamhi, PhD, RN, AHG, AHN-BC
 
Chapter 2 Drug Use Yesterday And Today
Chapter 2   Drug Use Yesterday And TodayChapter 2   Drug Use Yesterday And Today
Chapter 2 Drug Use Yesterday And Today
Justin Gatewood
 

Similar to Rx16 heroin tues_1115_1_walls_2kolodny (20)

Treating Substance Use Disorders in a Primary Care Setting
Treating Substance Use Disorders in a Primary Care SettingTreating Substance Use Disorders in a Primary Care Setting
Treating Substance Use Disorders in a Primary Care Setting
 
Treating Substance Use Disorders in a Primary Care Setting
Treating Substance Use Disorders in a Primary Care SettingTreating Substance Use Disorders in a Primary Care Setting
Treating Substance Use Disorders in a Primary Care Setting
 
Pharmaceutics I
Pharmaceutics I Pharmaceutics I
Pharmaceutics I
 
Chapter 1
Chapter 1Chapter 1
Chapter 1
 
Class 7 substance abuse
Class 7 substance abuseClass 7 substance abuse
Class 7 substance abuse
 
Dadspresentationfinal
DadspresentationfinalDadspresentationfinal
Dadspresentationfinal
 
History of _clinical_research (2)
History of _clinical_research (2)History of _clinical_research (2)
History of _clinical_research (2)
 
Regulations for drug approval in USA, E.U & India
Regulations for drug approval in USA, E.U & IndiaRegulations for drug approval in USA, E.U & India
Regulations for drug approval in USA, E.U & India
 
Drugs use and addiction
Drugs use and addictionDrugs use and addiction
Drugs use and addiction
 
Addiction Counselor Certification Training Series: Systems influences on mood...
Addiction Counselor Certification Training Series: Systems influences on mood...Addiction Counselor Certification Training Series: Systems influences on mood...
Addiction Counselor Certification Training Series: Systems influences on mood...
 
Student Loan ExerciseThis assignment is an exercise in getting.docx
Student Loan ExerciseThis assignment is an exercise in getting.docxStudent Loan ExerciseThis assignment is an exercise in getting.docx
Student Loan ExerciseThis assignment is an exercise in getting.docx
 
Chapter 1 pharmacy and health care
Chapter 1 pharmacy and health careChapter 1 pharmacy and health care
Chapter 1 pharmacy and health care
 
Michael-Ward
Michael-WardMichael-Ward
Michael-Ward
 
J. Listerman_Master's Thesis
J. Listerman_Master's ThesisJ. Listerman_Master's Thesis
J. Listerman_Master's Thesis
 
Goldberg Chapter 4
Goldberg Chapter 4Goldberg Chapter 4
Goldberg Chapter 4
 
Goldberg Chapter 4 Drugs & the Law
Goldberg Chapter 4 Drugs & the LawGoldberg Chapter 4 Drugs & the Law
Goldberg Chapter 4 Drugs & the Law
 
History that lead to Pharmacovigilance.pptx
History that lead to Pharmacovigilance.pptxHistory that lead to Pharmacovigilance.pptx
History that lead to Pharmacovigilance.pptx
 
Lecture 4 history and ethical codes
Lecture 4  history and ethical codesLecture 4  history and ethical codes
Lecture 4 history and ethical codes
 
Botanicals Scientific Validation of Herbal Medicine
Botanicals  Scientific Validation of Herbal Medicine Botanicals  Scientific Validation of Herbal Medicine
Botanicals Scientific Validation of Herbal Medicine
 
Chapter 2 Drug Use Yesterday And Today
Chapter 2   Drug Use Yesterday And TodayChapter 2   Drug Use Yesterday And Today
Chapter 2 Drug Use Yesterday And Today
 

More from OPUNITE

Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
OPUNITE
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
OPUNITE
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
OPUNITE
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
OPUNITE
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
OPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
OPUNITE
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
OPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
OPUNITE
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
OPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
OPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
OPUNITE
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
OPUNITE
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
OPUNITE
 
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerRx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
OPUNITE
 
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyWeb only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
OPUNITE
 
Rx16 federal visionsession_200
Rx16 federal visionsession_200Rx16 federal visionsession_200
Rx16 federal visionsession_200
OPUNITE
 
Rx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorinRx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorin
OPUNITE
 

More from OPUNITE (17)

Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
 
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerRx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
 
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyWeb only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
 
Rx16 federal visionsession_200
Rx16 federal visionsession_200Rx16 federal visionsession_200
Rx16 federal visionsession_200
 
Rx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorinRx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorin
 

Recently uploaded

CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
MGM SCHOOL/COLLEGE OF NURSING
 

Recently uploaded (20)

CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
 

Rx16 heroin tues_1115_1_walls_2kolodny

  • 1. Origins of the Heroin Crisis Presenters: • Phillip Walls, RPh, Chief Clinical Officer, myMatrixx • Andrew Kolodny, MD, Chief Medical Officer, Phoenix House Foundation, Inc., and Executive Director, Physicians for Responsible Opioid Prescribing Moderator: Jackie L. Steele, Jr., JD, Commonwealth Attorney, Kentucky 27th Judicial Circuit, and Vice Chairman, Operation UNITE Board of Directors Heroin Track
  • 2. Disclosures • Andrew Kolodny, MD, and Jackie L. Steele, Jr., JD, have disclosed no relevant, real or apparent personal or professional financial relationships with proprietary entities that produce health care goods and services. • Phil Walls, RPh - Employment and ownership interest: Matrix HCS, Inc.
  • 3. Disclosures • All planners/managers hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. • The following planners/managers have the following to disclose: – John J. Dreyzehner, MD, MPH, FACOEM – Ownership interest: Starfish Health (spouse) – Robert DuPont – Employment: Bensinger, DuPont & Associates-Prescription Drug Research Center
  • 4. Learning Objectives • Describe the history of heroin use in America, with emphasis on its relationship to the Rx drug abuse epidemic. • Identify key roles for pharmacists and other health professionals in identifying patients at-risk of heroin abuse. • Explain the relationship between the rising rates of opioid addiction, heroin use and overdose deaths. • Specify health interventions and policy responses to the heroin crisis. • Provide accurate and appropriate counsel as part of the treatment team.
  • 5. Heroin Track: Origins of the Heroin Crisis
  • 6. Why Focus on Heroin?
  • 7. • $177 billion – annual cost of prescription drug abuse to the US healthcare system • The Drug Enforcement Administration (DEA) estimates that diversion is a $25 billion-a-year industry • $8.5 billion – annual cost of hospital admissions for people who do not take their medications as prescribed How did this happen? Prescription Drug Abuse, Misuse and Diversion
  • 8. Timeline to Discovery of Heroin • 1806 – morphine isolated from opium poppy – named after Morpheus, the Greek god of dreams – Heinrick Emanuel Merck – converted pharmacy into a full-time producer of morphine – Engel-Apotheke or The Angel Pharmacy – Today known as Merck and Company • 1853 – invention of the hypodermic syringe and first injection of morphine – Co-invented by Alexander Wood and Charles Pravaz – Woods’ wife was the first fatality of an injected overdose of morphine Alexander Wood (1817 – 1884)
  • 9. Timeline to Discovery of Heroin • Dr. Woods’ discovery preceded the American Civil War by almost a decade – Approximately 400,000 soldiers became addicted to morphine – Characterized as “old soldiers’ disease” • One of these veteran’s was Colonel John Pemberton – A pharmacist by training – Mixed cocaine and the kola nut in an elixir to treat morphine withdrawal – Branded as Coca Cola in 1886 – Original formula with cocaine available until 1905 • 1874 - Diacetylmorphine is first synthesized
  • 10. Timeline to Discovery of Heroin Between 1878 and 1885 however opium addiction became much more widespread among middle- to upper-class white women
  • 11. Timeline to Discovery of Heroin • Diacetylmorphine is “re-discovered” by chemists working for Friedrich Bayer in the mid-1880’s through a process known as acetylation – Morphine → diacetylmorphine – Acetylsalicylic acid → aspirin • Bayer named this drug heroin after the German word heros meaning hero. Morphine Heroin The two drugs differ by the addition of two acetyl groups
  • 12. Metabolism of Opioids *Not comprehensive pathways, but may explain the presence of apparently unprescribed drugs †6-MAM=6-monoacetylmorphine, an intermediate metabolite Gourlay DL, et al. Urine Drug Testing in Clinical Practice: Dispelling the Myths & Designing Strategies [monograph]. 2004 hydrocodone heroin6-MAM† morphinecodeine hydromorphone oxycodone oxymorphone
  • 13. Timeline to Discovery of Heroin • Aspirin was first synthesized a year later – ironically aspiring required a prescription whereas heroin did not • Bayer and Merck had launched the start of the modern day pharmaceutical industry with the development of three of the world’s most popular analgesics: morphine, heroin and aspirin
  • 14. Trial Treatment – Free of Charge!
  • 16.
  • 17. Early Attempts at Regulation • 1906 – Pure Food and Drug Act – Coca Cola was one of few products that survived this legislation • 1914 – Harrison Narcotic Act • 1919 – ruling by the Supreme Court that it was unconstitutional to stop physicians from prescribing narcotics for addicts, but then the court later reversed that decision • The case of Alexander Ameris – characterized as a “dope fiend”
  • 18. Prevailing attitude early to mid- century 1900 • “…save our people from the clutches of this hydra- headed monster which stalks the civilized world, wrecking lives and happy homes, filling our jails and lunatic asylums…” Witherspoon JA. A protest against some of the evils in the profession of medicine. JAMA. 1900;34 :1589– 1592 1941 • “The use of narcotics in the terminal cancer patient is to be condemned … due to undesirable side effects … dominant in the list of these … is addiction” Lee LE Jr. Medication in the control of pain in terminal cancer. JAMA 1941;116:216-219
  • 19. The Vietnam War Era • Represented a turbulent time in American history • Janis Joplin dies of a heroin overdose on October 4, 1970 • The following May, Congressmen Steele and Murphy conducted an official visit to Vietnam • Their message upon returning: 15% of US servicemen in Vietnam were addicted to heroin • The timing coincided with the implementation of the Comprehensive Drug Abuse Prevention and Control Act of 1970 • On June 17th of 1971, President Richard Nixon characterized drug abuse as “a national emergency” - He asked Congress to amend the Narcotic Addict Rehabilitation Act of 1966 to increase access to methadone maintenance programs
  • 20. America’s War on Drugs • President Nixon’s legacy includes creation of the Drug Enforcement Administration in 1973 • 1975: the Ford administration names marijuana a low- priority drug • 1976: Carter campaigns for de-criminalization of marijuana • 1978: the Comprehensive Drug Abuse Prevention and Control Act is amended to allow law enforcement to seize “all things of value” involved in and exchange for controlled substances • 1981 – 1982: rise of the Medellin Cartel in Columbia and creation of a bilateral extradition treaty between the governments of Colombia and the United States
  • 21. America’s War on Drugs • 1984: Nancy Reagan launches her “Just Say No” campaign, which becomes a focal point of President Reagan’s anti-drug campaign • 1989: President Bush creates the Office of National Drug Control Policy (ONDCP) and campaigns to “make drug abuse socially unacceptable”. Spending for treatment and law enforcement increase under the ONDCP, but the budget for treatment is less than one-third that of law enforcement. • 1993: President Clinton signs the North American Free Trade Agreement (NAFTA). This agreement results in a significant increase in legitimate trade shipments across the Mexican-US border, but has the unintended consequence of making it difficult for US Customs agents to find contraband narcotics in these shipments. • 2000: President Clinton commits $1.3 billion in aid to Colombia to fight drug trafficking.
  • 22. America’s War on Drugs It is important to note in the War on Drugs that the DEA announced just this past May the most successful enforcement action in its history: known as Operation Pilluted, this operation resulted in 280 arrests including 22 doctors and pharmacists; resulted in the seizure of $11,651,565 US currency and $6,745,800 in real property.
  • 23. The Prescription Opioid & Heroin Crisis: Responding to an Epidemic of Addiction Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians for Responsible Opioid Prescribing Senior Scientist, Heller School for Social Policy and Management, Brandeis University
  • 24. Opium
  • 25. Primary non-heroin opiates/synthetics admission rates, by State (per 100,000 population aged 12 and over)
  • 26. Primary non-heroin opiates/synthetics admission rates, by State (per 100,000 population aged 12 and over)
  • 27. Primary non-heroin opiates/synthetics admission rates, by State (per 100,000 population aged 12 and over)
  • 28. Primary non-heroin opiates/synthetics admission rates, by State (per 100,000 population aged 12 and over)
  • 29. Primary non-heroin opiates/synthetics admission rates, by State (per 100,000 population aged 12 and over)
  • 30. Primary non-heroin opiates/synthetics admission rates, by State (per 100,000 population aged 12 and over)
  • 31. Non-heroin opioid treatment admissions: 2013 SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Treatment Episode Data Set (TEDS). Data received through 01.23.15.
  • 32. Unintentional overdose deaths involving opioid analgesics parallel per capita sales of opioid analgesics in morphine equivalents by year, U.S., 1997-2007 0 100 200 300 400 500 600 700 800 0 2000 4000 6000 8000 10000 12000 14000 '97 '98 '99 '00 '01 '02 '03 '04 '05 '06 '07 Source: National Vital Statistics System, multiple cause of death dataset, and DEA ARCOS * 2007 opioid sales figure is preliminary. Number of Deaths Opioid sales (mg/person) *
  • 33. 0 1 2 3 4 5 6 7 8 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 Rate Year Opioid Sales KG/10,000 Opioid Deaths/100,000 Opioid Treatment Admissions/10,000 Rates of Opioid Sales, OD Deaths, and Treatment, 1999–2010 CDC. MMWR 2011
  • 34.
  • 35.
  • 36. Source: United States General Accounting Office: Dec. 2003, “OxyContin Abuse and Diversion and Efforts to Address the Problem.” Dollars Spent Marketing OxyContin (1996-2001)
  • 37. Industry-funded “educational” messages • Physicians are needlessly allowing patients to suffer because of “opiophobia.” • Opioid addiction is rare in pain patients. • Opioids can be easily discontinued. • Opioids are safe and effective for chronic pain.
  • 38. Industry-funded organizations campaigned for greater use of opioids • Pain Patient Groups • Professional Societies • The Joint Commission • The Federation of State Medical Boards
  • 39. Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med. 1980 Jan 10;302(2):123 Cited 824 times (Google Scholar) “The risk of addiction is much less than 1%”
  • 40. N Engl J Med. 1980 Jan 10;302(2):123.
  • 41. 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 22,000 24,000 26,000 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Painkillers Heroin Total Opioid Year Opioid Related Overdose Deaths: 1999-2013
  • 42. Heroin treatment admissions : 2003-2013 SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Treatment Episode Data Set (TEDS). Data received through 01.23.15.
  • 43. Death rates from overdoses of heroin or prescription opioid pain relievers (OPRs), by age group SOURCE: CDC. Increases in Heroin Overdose Deaths — 28 States, 2010 to 2012 MMWR. 2014, 63:849-854
  • 44. Heroin admissions, by gender, age, and race/ethnicity: 2013 SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Treatment Episode Data Set (TEDS). Data received through 01.23.15.
  • 45. Deaths involving heroin, by age and race/ethnicity 2000 and 2013
  • 46. Controlling the epidemic: A Three-pronged Approach • Prevent new cases of opioid addiction. • Treatment for people who are already addicted • Reduce supply from pill mills and the black- market.
  • 47. How the opioid lobby frames the problem: Source: Slide presented by Lynn R. Webster MD at FDA meeting on hydrocodone upscheduling, January 25th, 2013.
  • 48. Pain Patients “Drug Abusers” 35% met DSM V criteria for an opioid use disorder1 1. Boscarino JA, Rukstalis MR, Hoffman SN, et al. Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria. J Addict Dis. 2011;30:185-194. This is a false dichotomy Opioid harms are not limited to so-called “drug abusers” 92% of opioid OD decedents were prescribed opioids for chronic pain.2 2. Johnson EM, Lanier WA, Merrill RM, et al. Unintentional Prescription Opioid-Related Overdose Deaths: Description of Decedents by Next of Kin or Best Contact, Utah, 2008-2009. J Gen Intern Med. 2012 Oct 16.
  • 49.
  • 50. Heroin treatment admissions with planned medication-assisted opioid therapy 2003-2013 SOURCE: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Treatment Episode Data Set (TEDS). Data received through 01.23.15.
  • 51. Summary • The U.S. is in the midst of a severe epidemic of opioid addiction • To bring the epidemic to an end: – We must prevent new cases of opioid addiction – We must ensure access to treatment for people already addicted
  • 52. Origins of the Heroin Crisis Presenters: • Andrew Kolodny, MD, Chief Medical Officer, Phoenix House Foundation, Inc., and Executive Director, Physicians for Responsible Opioid Prescribing • Phillip Walls, RPh, Chief Clinical Officer, myMatrixx Moderator: Jackie L. Steele, Jr., JD, Commonwealth Attorney, Kentucky 27th Judicial Circuit, and Vice Chairman, Operation UNITE Board of Directors Heroin Track